BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.medilinkmidlands.com X-WR-CALDESC:Events for Medilink Midlands REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:Europe/London BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20220327T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20221030T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20230326T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20231029T010000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:+0000 TZOFFSETTO:+0100 TZNAME:BST DTSTART:20240331T010000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:+0100 TZOFFSETTO:+0000 TZNAME:GMT DTSTART:20241027T010000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=Europe/London:20230307T093000 DTEND;TZID=Europe/London:20230307T113000 DTSTAMP:20260403T215945 CREATED:20230214T135008Z LAST-MODIFIED:20230228T142302Z UID:22214-1678181400-1678188600@www.medilinkmidlands.com SUMMARY:WEBINAR: A Practical Guide to Achieving Net-Zero – What it Means for the Healthcare Supply Chain DESCRIPTION:This online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \n  \nFollowing on from the face-to-face event held in December\, this online event will continue to examine the ambitious sustainable goals set out by the government and the NHS\, and how you\, as a life sciences or health care organisation\, need to adapt to meet the requirements of the customer (NHS). Plus\, it will explore how you can lead the way to achieving net zero and a sustainable organisation. \nAttend this free session to find out: \n\nOverview of NHS needs\nSupport available from the AHSN\nExamples of innovation driving greener healthcare\nHow to measure and reduce your own emissions and save energy costs\nHow to reduce emissions and save energy costs.\n\nOur panel of guest speakers include: \n\nHelen Black\, Transformation and Net Zero Delivery Lead\, NHS England – Midlands\nPete Waddingham\, National NetZero Lead\, The AHSN Network\nOlivia Simpson\, CEO & Co-Founder\, SymbioTex\nDavid Abosch\, Director\, Cognition Cloud\nAdam Wright\, Chief Operating Officer\, Zellar\n\nTo secure your free place click here\nSpeaker company profiles: \nThe AHSN Network \nAcademic Health Science Networks (AHSNs) bring together the NHS\, industry\, academic\, third sector and local organisations. Our collaboration ensures innovations\, improvements and best practice benefit more patients faster. \nOur national innovation pipeline features more than 1\,200 proven technologies ready to be matched to local health and care challenges. \nSymbioTex is a west midlands based company started by two university of Wolverhampton students. It focuses on utilising seaweed and waste biomass to produce home compostable semi ridged bioplastics – with the goal of producing class 1 medical devices such as inhalers\, pregnancy test and other diagnostic tests. \nCognition Cloud helps organisations to understand the environmental impact of their Information Technology and provides services to help them mitigate it. \nCognition Cloud is able to provide organisations a baseline measurement of the embedded GHG emissions in their desktops and laptops. Their services then help them to significantly cut these emissions over time. \nZellar is the UK’s leading sustainability platform\, helping businesses on their journey to Net Zero in the fastest\, most efficient and cost-effective way. \nReducing energy usage in the current climate\, even by 20%\, is likely to have a significant impact on businesses’ bottom line. Every business needs to become sustainable; their customers\, employees and stakeholders will be demanding it. \nThe Midlands is leading the way\, hear how the Zellar platform can support your business and the planet. URL:https://www.medilinkmidlands.com/event/webinar-a-practical-guide-to-achieving-net-zero-what-it-means-for-the-health-care-supply-chain/ LOCATION:Online CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230314T093000 DTEND;TZID=Europe/London:20230314T113000 DTSTAMP:20260403T215945 CREATED:20230217T072641Z LAST-MODIFIED:20230223T120139Z UID:22278-1678786200-1678793400@www.medilinkmidlands.com SUMMARY:Selling into the NHS & Understanding your Market DESCRIPTION:This online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nCLICK HERE TO BOOK YOUR PLACE\nThis webinar will provide you with an overview of the fundamental steps you need to take to  understand your market\, and your customer (NHS). Our guest speakers will share their expert knowledge in selling and preparing businesses to gain access to and sell into the NHS and health care providers. Offering advice and guidance on what is required by the NHS and others to initiate and make a sale of medical innovation. \nHear from Kate Pym\, Managing Director of Pym’s Consultancy Ltd who will cover: \n\nTimeline considerations\n\nMarket evaluation and assessment\nCustomer discovery\nFunding\nMarketing\nSales\nProduct development pipeline\nExit strategy\n\n\nUnderstanding Your Market\n\nStructures and services within the NHS\nIntegrated Care – ICS\nMarket entry points\nCompetitor analysis\nMarket size\nMarket value\nQoF\, CQUINS\, PbR\, national strategies\nInternal market competition (NHS vs private work)\n“it’s different here” – working at a trust level\n\n\nUnderstanding Your Customer\n\nFocusing on a point of access\nPosition of product/service in clinical pathway\nIdentifying buyers and stakeholders\nIncentives and drivers for stakeholder\nBudgets and autonomy\n\n\n\nOur second guest speaker\, Bob Roopra\, Managing Consultant of Roopra Medtech Consulting\, will expand on this subject\, and offer real life examples and re- affirm\, ‘it’s all about the plan!’ \nIncluding: \n\nPreparing a business to sell its new innovations into the NHS\nKey items a company must consider\nExamples of big and small medtech business – their success and lessons learnt\, and how the correct approach and preparation can lead to benefits\, such as funding and investment.\nSteps to successful launches and sales. \n\nSpeaker profiles: \nKate Pym AMIHM (mid)\, Managing Director of Pym’s Consultancy Ltd \nPym’s Consultancy Ltd is an independent consultancy providing services for SMEs and universities supporting grant applications\, responses to tender and commercialisation \nKate has over 25 years’ experience of working in Health and Social Care for companies\, including Allergan Inc.\, AstraZeneca\, Mitie and Baxter Healthcare. With a focus on innovative products and services. She has worked across the NHS\, public\, private and third sectors to produce patient-centred\, high quality\, outcome based services and facilitate the market entry and growth of new products. \nKate’s experience covers: Product launches\, writing winning bids\, working with commissioners to model population outcomes\, designing\, selling and mobilization of new health\, social care and integrated services. She has a clear focus on outcomes and what is required to demonstrate them\, with a view to market entry\, extension and expansion of constructive innovation. \nBob Roopra MBA FCMI\, Managing Direcor of Roopra Medtech Consulting Ltd. \nBio/photo to follow. URL:https://www.medilinkmidlands.com/event/sellingintothenhsknowyourmarketrket/ LOCATION:Online CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230316T100000 DTEND;TZID=Europe/London:20230316T110000 DTSTAMP:20260403T215945 CREATED:20230222T124422Z LAST-MODIFIED:20230222T124422Z UID:22396-1678960800-1678964400@www.medilinkmidlands.com SUMMARY:WEBINAR: The State of the Nation Cyber Webinar Series Part 1 - Cyber Risk Quantification DESCRIPTION:Join Gallagher for part one of this year’s State of the Nation Cyber Webinar Series – Cyber Risk Quantification – Measuring the Cost of Cyber Risk Exposure. \nHow much should we invest in a new security control? What level of cyber insurance coverage do we need? Are we reducing the amount of cybersecurity risk within our business\, and if so\, by how much? \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nThese are questions that boards around the world are struggling to answer in the current environment. Traditional qualitative methods of measuring the level of cyber risk within an organisation currently do not provide accurate enough information to answer these questions. A more robust\, probabilistic and scenario-driven type of analysis is required. That’s where cyber risk quantification comes into its own. \nIn this webinar\, Gallagher cyber specialists will discuss this burgeoning field of risk quantification\, and explore: \n\nWhy traditional Cyber risk ‘heat maps’ are not up to scratch.\nWhat Risk Quantification involves\, and the methodology that it employs.\nHow small amounts of information and data can still provide key insights.\nHow Risk Quantification can help guide business decisions\, including control investment and insurance limits.\n\nThe key takeaways from this session will include how business leaders can use risk quantification to aid in their decision-making and leverage the Gallagher Cyber Risk Quantification service to provide key insights into the level of risk they face\, and where investments could make the biggest difference. \n\nSpeakers\n\n Johnty Mongan\, Head of Cyber Risk Management at Gallagher\n John Clarke\, Consulting Manager\, Cyber Risk Management at Gallagher\n\nFormat\n\nPanel discussion followed by audience Q&A. URL:https://www.medilinkmidlands.com/event/webinar-the-state-of-the-nation-cyber-webinar-series-part-1-cyber-risk-quantification/ CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230316T190000 DTEND;TZID=Europe/London:20230316T230000 DTSTAMP:20260403T215945 CREATED:20211027T095016Z LAST-MODIFIED:20230223T124437Z UID:20138-1678993200-1679007600@www.medilinkmidlands.com SUMMARY:Medilink Midlands Business Awards 2023 DESCRIPTION:With thanks to our Headline Sponsors\, the University of Birmingham and the Precision Health Technologies Accelerator. \n \nThe Medilink Midlands Business Awards will once again provide a stage to showcase the very best collaborations between industry\, academia and the NHS across the Midlands. \n\n\n\n\n\n\n\n\n\nWe come together each year to celebrate the achievements of life science companies\, which for 2023 will be hosted in the Great Hall\, set in the grounds of the University of Birmingham.  A truly outstanding venue\, to complement our outstanding finalists. \nThis is a fantastic opportunity for the Midlands life science community to gather together\, celebrate and network. \nCeremony & Dinner \nThe awards ceremony will be held at the Great Hall\, University of Birmingham on Thursday 16 March 2023. \nTickets \nCLICK HERE TO SECURE YOUR TICKETS\nMember individual: £99 / Member table*: £850 \nTo receive the discounted Medilink Member rate\, you will need to enter the promotional code at checkout. If you have not received your code\, please contact info@medilinkmidlands.com \nNon Member individual: £135 / Non Member table*: £1\,200 \n*table of x 10 \nplus VAT. \nHotel Accommodation \nMedilink has a small allocation of bedrooms secured at The Edgbaston Park Hotel. Please get in touch if you would like to secure your bedroom(s) at info@medilinkmidlands.com. URL:https://www.medilinkmidlands.com/event/medilink-midlands-business-awards-2022-2/ LOCATION:The Great Hall\, University of Birmingham\, Birmingham\, B15 2TN\, United Kingdom CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Medilink Midlands":MAILTO:zoeh@medilinkwm.co.uk END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230323T090000 DTEND;TZID=Europe/London:20230323T100000 DTSTAMP:20260403T215945 CREATED:20230309T121909Z LAST-MODIFIED:20230321T115747Z UID:22580-1679562000-1679565600@www.medilinkmidlands.com SUMMARY:WEBINAR: Selling To The NHS: How Procurement Operates DESCRIPTION:                              \nThis online event is part of the West Midlands Academic Health Science Network (WMAHSN) industry event programme\, aimed to support the West Midlands innovation ecosystem\, and to make the West Midlands healthier\, more productive and deliver the best possible clinical outcomes for patients. \nCLICK HERE TO BOOK YOUR PLACE\nOur second in the series of procurement focused webinars\, this one-hour session will be delivered by Simon Clarke\, Managing Director\, BSOL Procurement Collaborative (Procurement lead – Birmingham and Solihull ICS). Simon will share his wealth of experience working with the NHS and innovators to sell to the NHS and how the NHS procurement system operates. \nTopics covered will include: \n\nWho are BSOL Procurement Collaborative\, what do they deal with and what do they require?\nOverview of the NHS procurement operation and where BSOL Procurement Collaborative sits amongst the range of Procurement entities.\nHow should industry approach NHS procurement and what should they present to get their attention and time.\nWhere do Frameworks and National procurement fit with the BSOL Procurement Collaborative?\nWho should industry approach first and why?\nWhere does industry go wrong? Common errors and faux pas when selling to BSOL Procurement Collaborative / NHS as well as several ‘must dos’.\nRegulatory considerations\nDo BSOL Procurement Collaborative evaluate / try products? Or get engaged with Health Economics for companies?\nPlans for sustainability and net zero.\nSelling to an ICB\nOther opportunities URL:https://www.medilinkmidlands.com/event/webinar-selling-to-the-nhs-how-procurement-operates/ CATEGORIES:Medilink Midlands Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230323T130000 DTEND;TZID=Europe/London:20230323T170000 DTSTAMP:20260403T215945 CREATED:20230302T095125Z LAST-MODIFIED:20230302T095125Z UID:22474-1679576400-1679590800@www.medilinkmidlands.com SUMMARY:ONLINE EVENT: TBAT Innovation Challenge 2023 - Workshop 1 - Finance DESCRIPTION:Join TBAT Innovation\, Shakespeare Martineau and Modus Accountants\, along with other partners for the first of the Innovation Challenge workshops to discover all you need to know to fund your business growth and innovation. They will discuss problems\, challenges and highlight opportunities to reduce the effects of funding barriers – supporting on the journey to commercialisation and being a disrupter in the marketplace. \nFor more details of this first workshop\, click here. \nThis event forms part of the wider TBAT Innovation Challenge 2023. \nThe Innovation Challenge is brought to you by TBAT Innovation with headline sponsor Shakespeare Martineau and has been designed by our expert team to stimulate and support innovation in SMEs. It leverages the expertise of our unique partner network while seeing our partners come together to deliver four free to attend\, vibrant and informative workshops. \nOnce our final workshop has concluded in June\, the final stage of The Innovation Challenge will open. We will invite applications for businesses to submit a full business plan to be considered for our exciting prize package. \nThe winner will receive a £5\,000 cash prize and support packages from partners involved in The Innovation Challenge\, tailored to their needs. Furthermore\, two runners up will receive a free support package from partners involved in The Innovation Challenge. \nWe will be hosting a final showcase event in October 2023 to announce the winner from 10 finalists who will be invited to pitch their business plan in 3 minute presentation in front of key investors. \nThe Application window will open March 23rd\, with further details on how to apply to be announced.  URL:https://www.medilinkmidlands.com/event/online-event-tbat-innovation-challenge-2023-workshop-1-finance/ LOCATION:Online CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230327 DTEND;VALUE=DATE:20230401 DTSTAMP:20260403T215945 CREATED:20230308T135737Z LAST-MODIFIED:20230308T135737Z UID:22555-1679875200-1680307199@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: Health Data Immersion Week: Working With Real World Data DESCRIPTION:The University of Birmingham’s Institute for Interdisciplinary Data Science and AI has partnered with Health Data Research UK to deliver a series of intensive courses (immersion weeks)\, intended to enable individuals with skills in mathematics and computational science to gain insight into key topics in health data science. \nOur upcoming course taking place at the end of March is delivered in collaboration with University Hospitals Birmingham\, through the HDR UK supported PIONEER Data Hub. It will be of particular interest to anyone wishing to gain an understanding of the potential and challenges of real-world health data\, and practical experience of working with such data. \n  \nCLICK HERE TO BOOK YOUR  PLACE TODAY\n  \nCourse Title: Working with Real-World Data \nDates: Monday 27th to Friday 31stMarch 2023 \nLocation: University of Birmingham (in-person only) \nRegistration Fee: £400\,with a discounted rate of £250 for registered students (small number of stipends available) \nTo find out more & apply: https://www.birmingham.ac.uk/research/data-science/health-data-training/health-data-immersion-week-real-world-data.aspx URL:https://www.medilinkmidlands.com/event/in-person-event-health-data-immersion-week-working-with-real-world-data/ LOCATION:University of Birmingham\, Winterbourne House\, Edgbaston\, Birmingham\, B15 2TT\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230328T130000 DTEND;TZID=Europe/London:20230328T140000 DTSTAMP:20260403T215945 CREATED:20230322T152931Z LAST-MODIFIED:20230328T080419Z UID:22797-1680008400-1680012000@www.medilinkmidlands.com SUMMARY:EMAHSN Innovation Academy - Live Q&A - Module I: Considerations for Spread and Adoption DESCRIPTION:PLEASE NOTE: We are aware that some people have recently experienced issues registering for / logging into their EMAHSN Innovation Academy account. We believe this issue to now be resolved\, but please email teresao@medilinkmidlands.com if you have any difficulties registering for this module. \nThe East Midlands Academic Health Science Network Innovation Academy is open to anyone to register. Once registered\, participants will have access to a range of modules\, each including a webinar\, live Q&A session with the experts and online resources. The webinars are on demand\, so can be accessed at any time\, with the live Q&A session for each module being scheduled throughout 2023. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to Sign up for the Academy and to register for this module.\nThis module explores innovation\, adoption and spread within the NHS. Tony will discuss the key factors which should be considered if your innovation is replicating another or improvement across multiple locations. He will also cover what needs to be thought about if your innovation is new to the NHS and how you can provide evidence that your product significantly improves the quality of health and care. \nTony will also give you the knowledge required for you to put a completely new innovation into practice\, all whilst making you think about the logic behind your innovation! \nPresenter\n\n\n \n\n\nTony Doyle – Managing Director\, Qbtech & NHS Innovation Accelerator Fellow 2020 \n \nJulian Patel\, Associate Director (Innovation Partnerships & Business Development)\, East Midlands Academic Health Science Network (EMAHSN) \n \nMark Dines-Allen\, Senior Programme Consultant\, EMAHSN \n \nTim Robinson\, Commercial Director\, EMAHSN URL:https://www.medilinkmidlands.com/event/emahsn-innovation-academy-module-i/ LOCATION:Online – GoToMeeting CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230329T093000 DTEND;TZID=Europe/London:20230329T124500 DTSTAMP:20260403T215945 CREATED:20230309T140100Z LAST-MODIFIED:20230309T141718Z UID:22604-1680082200-1680093900@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: From Ideas to Adoption: Marketing and Market Access Strategies for Life Science Innovators DESCRIPTION:Join us for this workshop hosted by the University of Leicester Life Sciences Accelerator (LLSA). You will learn the key skills and strategies to bring your life science innovations to market and drive adoption in a complicated sector. The workshop will take place at Charnwood Campus\, Loughborough on 29 March 2023. Refreshments and lunch will be provided on the day. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY \nThe workshop consists of two sessions:\n\nContextualising your Idea – Marketing Fundamentals: \n\nHelping you to understand how to create and articulate value for your customers by offering them innovations that meet the needs of the customer and end users in the life sciences sector. The session will provide you with skills on how to research your market\, position your idea and freedom to operate in a competitive market. \n\nShaping the Market for Adoption – Market Access Fundamentals: \n\nHelping you to understand how to shape the market opportunity for your idea and navigate the barriers to market access. This session disseminates the skills needed to explore your innovation’s market opportunity by assessing the routes to market\, developing effective communication strategies and building advocacy to drive adoption. \nAgenda:\n\n09:30 – Arrival\, Registration and Refreshments\n10:00 – Contextualising your Idea – Marketing Fundamentals (75 mins)\n11:15 – Refreshments\n11:30 – Shaping the Market for Adoption – Market Access Fundamentals (75 mins)\n12:45 – Lunch and Close\n\nThe Leicester Life Sciences Accelerator delivers free innovation support to regional life sciences SMEs to increase knowledge exchange between clinicians\, academics and local companies to accelerate product development in partnership with the Midlands Engine and is part funded by the European Regional Development fund. URL:https://www.medilinkmidlands.com/event/in-person-event-from-ideas-to-adoption-marketing-and-market-access-strategies-for-life-science-innovators/ LOCATION:Charnwood Campus Loughborough\, LE11 5RB\, Charnwood Campus Loughborough\, Loughborough\, LE11 5RB\, United Kingdom CATEGORIES:Medilink Midlands Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230414T080000 DTEND;TZID=Europe/London:20230414T100000 DTSTAMP:20260403T215945 CREATED:20230406T100758Z LAST-MODIFIED:20230406T100758Z UID:23029-1681459200-1681466400@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: The King's Awards for Enterprise event for Wolverhampton businesses DESCRIPTION:The King’s Awards for Enterprise are a prestigious set of awards given annually to UK-based businesses that demonstrate exceptional achievement in areas such as innovation\, international trade\, sustainable development and promoting opportunity through social mobility. \nHear direct from Wolverhampton Deputy Lieutenant Professor Martin Levermore MBE and Deputy Lieutenant John Wood\, who will outline the process involved and answer any questions you may have. \nCLICK HERE TO BOOK YOUR PLACE\nWinning a King’s Award is widely considered to be a hallmark of business excellence and can bring numerous benefits to your business: \n\nIncreased brand recognition and credibility\nImproved marketing opportunities\nNetworking opportunities\nAccess to funding and grants\nImproved employee morale\n\nThe awards are valid for 5 years. Winners have reported benefiting from worldwide recognition\, increased commercial value\, greater press coverage and a boost to staff morale. Hear from previous Queen’s Awards winners sharing their experience. \nThose who gain an award will be: \n\nInvited to a Royal reception\nPresented with the award at your company by one of The King’s representatives\, a Lord-Lieutenant\nAble to fly The King’s Awards flag at your main office\, and use the emblem on your marketing materials (for example\, on your packaging\, advertisements\, stationery and website)\nGiven a Grant of Appointment (an official certificate) and a commemorative crystal trophy\n\nThe 2024 awards will open for entries in May 2023 with a closing date early in September 2023. \nFor more information about The King’s Awards for Enterprise\, please click here. URL:https://www.medilinkmidlands.com/event/in-person-event-the-kings-awards-for-enterprise-event-for-wolverhampton-businesses/ LOCATION:Wolverhampton Art Gallery CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230418T093000 DTEND;TZID=Europe/London:20230418T153000 DTSTAMP:20260403T215945 CREATED:20230329T143653Z LAST-MODIFIED:20230331T102028Z UID:22923-1681810200-1681831800@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: Empowering Women in Biotech DESCRIPTION:Taking place on 18th April between 9.30am – 3.30pm\, this event aims to bring together likeminded individuals working in the biotech and life science sector\, and women looking to pursue a career in this industry. We will have talks from inspirational women in the industry on topics ranging from leadership and the visibility of women in biotech\, investment opportunities available\, and ways to connect with one another. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nAim of the Event:\n\nShare personal and professional experiences and career strategies from a woman’s perspective.\nHelp women\, wherever they are in the career paths\, realise their future goals.\nEncourage women to enter and maintain careers in Biotech.\nGenerate a wider network of professionals working in Biotech.\n\nWho is it for?\nThis is an inclusive event and all are welcome particularly:\n-Women in academia and industry who would like to network\n-Women who would like to learn about and explore the opportunities available to them \nThis event is in partnership with Bionow\, Charnwood Molecular\, Charnwood Campus\, IBioIC\, Potter Clarkson\, SynBioBeta and WiSB (Women in Synthetic Biology) \nA great opportunity for academic and industry colleagues to get together. \nFor any further information please contact mollie.nolan@bionow.co.uk URL:https://www.medilinkmidlands.com/event/in-person-event-empowering-women-in-biotech/ LOCATION:Charnwood Molecular CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230419T100000 DTEND;TZID=Europe/London:20230419T110000 DTSTAMP:20260403T215945 CREATED:20230208T154023Z LAST-MODIFIED:20230315T121835Z UID:22155-1681898400-1681902000@www.medilinkmidlands.com SUMMARY:WEBINAR: Are Your Promotional Materials Compliant? DESCRIPTION:From websites\, conference collateral\, digital/printed ads\, audio-visual material through to prescribing information; promotional copy requires a technical review in order to prevent violations of industry codes and to ensure that legal guidelines are followed. \nJensonR+ work with you to make the promotion and launch of your product a success. They provide both medical and regulatory review and certification services for promotional copy through our team of registered copy approvers. JensonR+ can review your promotional literature\, advise you on campaign strategy and key messages\, and obtain regulatory approval through pre-vetting where necessary. \nJoin us for this free-to-attend webinar\, which gives an overview of the following topics\, what copy approval is\, and why it is required: \n\nPrescription-only medicines\nOver-the-counter medicines\nFood supplements\n\n\n\n\nCosmetics\nMedical Devices\nEvents and conference compliance\nProofreading services\n\n\n\nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nSpeaker Profiles\n \nJames Hall\, Director\, JensonR+ \nJames joined JensonR+ Ltd in 2012 and has over 25 years’ regulatory experience predominantly in the OTC sector of the industry. \nHis background covers a wide spectrum of areas including regulatory strategy and implementation\, borderline products\, promotional copy approval\, reclassifications\, medical devices and pharmacovigilance. James has worked with several major pharmaceutical companies and a wide scope of entrepreneurial clients. He is a board member within JensonR+ Ltd. \nJames has a degree in Applied Biology and is a fellow of TOPRA. \nHis role within Jenson covers business development\, regulatory strategy and implementation for clients\, promotional copy review and regulatory team management. \n \nMihai Inceu\, Senior Regulatory Officer\, JensonR+ \nMihai is currently based in London and Nottingham for JensonR+ Ltd. While at the Faculty of Chemistry in Cluj-Napoca\, Mihai was awarded a research scholarship for a study monitoring pesticide residue in Romanian wines\, while also working on developing extraction techniques to enable the identification of fake food products on the market. \nAfter a short spell at Ranbaxy as a Bioequivalence Scientist\, Mihai worked for 5 years at Nelsons within quality control\, quality assurance\, and later Regulatory Affairs\,  where he focused on food supplements\, cosmetics\, traditional herbal remedies and homeopathic remedies. He has expertise in regulatory complications relating to uncategorised products URL:https://www.medilinkmidlands.com/event/compliance-approval/ LOCATION:Online CATEGORIES:Featured,Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230420T140000 DTEND;TZID=Europe/London:20230420T153000 DTSTAMP:20260403T215945 CREATED:20230323T140114Z LAST-MODIFIED:20230323T140114Z UID:22825-1681999200-1682004600@www.medilinkmidlands.com SUMMARY:WEBINAR: SEHTA & Psephos Biomedica Taster: MHRA Clinical Investigations: Best Practice and Future Insights DESCRIPTION:              \n\n\n\nSEHTA’s MDR Regularory Partner Psephos Biomedica are delighted to bring you this FREE to attend taster webinar session on MHRA Clinical Investigations to help you get up to to date on the latest developments and understand the approval process plus future insights.\n\n\n\nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\n\nSpeaker Profiles\n  \n \nRobin Stephens\, CEO & Co-Founder\, Psephos Biomedica \nPresentation Title: Insights into the future at MHRA / in the UK \n \nMark Grumbridge\, Head of Clinical Investigations\, MHRA \nPresentation Title: Clinical investigations – approval process and best practice \n\n\n\n\n\n\n\n\n\n\n\nWhy attend?\nThe UK has always fostered a clinical research friendly environment aiming to advance disease diagnosis\, medical therapies and improved patient care. With an increasing interest in medtech clinical investigations this webinar will provide an overview of the UK Medicines and Health products Regulatory Agency (MHRA) process for research clearance\, advice and support. If you are involved in clinical investigations in the UK at any level this informative webinar is for you. \nWho should attend?\nClinical research staff (VP\, Director\, Manager\, Specialist\, Associate); medtech entrepreneurs; regulatory staff (VP\, Director\, Manager\, Specialist\, Associate); anyone interested in the future of medtech clinical research in the UK.\n\n\n\n\n\n\n\n  \n  URL:https://www.medilinkmidlands.com/event/webinar-sehta-psephos-biomedica-taster-mhra-clinical-investigations-best-practice-and-future-insights/ CATEGORIES:Medilink Partner Event END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230425 DTEND;VALUE=DATE:20230427 DTSTAMP:20260403T215945 CREATED:20230222T122112Z LAST-MODIFIED:20230222T122112Z UID:22348-1682380800-1682553599@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: BIOTRINITY 2023: Catalysing Growth in the Life Sciences Industry DESCRIPTION:BioTrinity is an established\, must-attend London conference\, that catalyses growth and supports in-person engagement across the life sciences industry. \nThe event is attended by an audience of early stage and emerging life sciences R&D Companies\, investors\, big pharma\, and other valued partners throughout the life sciences ecosystem. The conference features a focused\, relevant\, and stimulating programme\, led by great speakers\, who bring their knowledge\, expertise\, and vision to the fore in exciting\, high-quality sessions. \nInteracting with new companies each year is something we believe to be a critical attribute of a successful conference and we work hard to ensure that a substantial and fresh line-up of investable opportunities and collaboration possibilities are showcased. \nCLICK HERE TO BOOK YOUR PLACE TODAY\nBioTrinity features: \n\nA dedicated ‘Scientific Track’\, featuring a focus on eight core therapy areas; Oncology\, Neuroscience\, Microbiome\, Inflammatory Diseases\, Rare Diseases\, Infectious Diseases\, Medtech and Cell & Gene Therapy. Each dedicated session will include an expert update from a key opinion leader\, followed by up to 5 showcase presentations from some of the most innovative and interesting R&D companies.\nA second ‘life sciences business’ focused presentation track\, that will feature discussions and keynotes addressing topics from finance and investment\, regulatory\, government strategy and tax.\nPre-scheduled live & in-person private partnering meetings during the two-day physical conference as well as a bonus third day of virtual only partnering.\nA sponsors exhibition area and plenty of ‘all-delegate’ networking opportunities throughout both in-person day\, which are so valuable to share knowledge and unlock future collaboration and new business opportunities.\nOption for registered delegates to revisit recorded presentations in the days following the conference.\nBioTrinity Investor Drinks Reception 24 April and BioTrinity Networking Party 25 April events open to conference delegates.\n\nFor more information click here. \n  URL:https://www.medilinkmidlands.com/event/in-person-event-biotrinity-2023-catalysing-growth-in-the-life-sciences-industry/ LOCATION:155 Bishopsgate\, London\, 155 Bishopsgate\, London\, London\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230425T090000 DTEND;TZID=Europe/London:20230425T153000 DTSTAMP:20260403T215945 CREATED:20230222T121747Z LAST-MODIFIED:20230302T120218Z UID:22378-1682413200-1682436600@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: Driving Innovation in Midlands Healthcare DESCRIPTION:                                                                                       \nA Charnwood Campus NHS and Academia Collaboration Platform event\, part of a series of events and workshops to support the growth and success of the life science organisations clustered around Charnwood Campus Science\, Innovation and Technology Park. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nAre you developing a new healthcare product\, drug or biomarker? \nAre you interested in these therapeutic areas? \n\nRespiratory\nCancer\nDiabetes and Lifestyle\nCardiovascular\n\nAre you looking for a clinical or academic partner? \nAre you looking for new research to commercialise? \nAre you considering a Precision Medicine approach for your product? \nWould you like to have 1-2-1 discussions with world leading clinical and academic experts? \nWould you like to develop collaborative projects to de-risk new product development? \nOur event aims to grow and develop research partnerships between Industry and the University of Leicester. To facilitate this\, pump-prime funding of up to £5K per project will initially be available to help early-stage project development with potential partners following on from this event. \nFor further information on the funding available and how to book slots with the speakers\, please contact Dr Lynne Howells at lh28@le.ac.uk or iph@le.ac.uk \n\nAgenda\n9.00 – 9.20 Registration Refreshments and Poster Exhibition. \n9.20 – 10.10 Event Welcome and Introduction to the Institute of Precision Health/Clinical Translation of Respiratory Research. \nProfessor Chris Brightling\, Co-Director University of Leicester Institute for Precision Health\, Honorary Consultant Respiratory Physician\, Respiratory Theme Lead for Leicester NIHR Biomedical Research Centre (Respiratory). \n10.10 – 10.30 Developing the Liquid Biopsy for Cancer Diagnostics. \nProfessor Jacqui Shaw\, Co-Director University of Leicester Institute for Precision Health\, Head of Department Genetics and Genome Biology (Genetics). \n10.30 – 10.50 Clinical evaluation and enhancing uptake of MedTech to improve outcomes in diabetes. \nProfessor Pratik Choudhary\, Honorary consultant in Diabetes\, Leicester Diabetes Centre. Chair of Diabetes Technology Network UK. \n10.50 – 11.20 Refreshments and Networking Break. \nPre-book your 10-minute slot with one of our speakers. \n11.20 – 11.40 Introduction to the PROTAC pipeline. \nDr James Hodgkinson\, Associate Professor of Chemistry and Chemical Biology\, School of Chemistry. \n11.40 – 12.00 Developing Novel Biomarkers for Disease Detection. \nProfessor Don Jones\, Co-Director University of Leicester Institute for Precision Health\, Director of van Geest MultiOMICS facility and Dr Jim Langridge\, Waters (Biomarkers). \n12.00 – 1.40 Lunch and Networking Break. \nPre-book your 10-minute slot with one of our speakers. \n1.40 – 2.00 Industry Talk. \n2.00 – 2.30 Industry collaborations advancing novel cardiac risk prediction tools to the clinic. \nProfessor Andre Ng\, Head of Department\, Cardiovascular Sciences\, Professor of Cardiac Electrophysiology\, Consultant Cardiologist and Electrophysiologist. \n2.30 – 2.50 How Companies can Access Funded Projects. \nDr Lucy Alexander\, Head of Business Development\, Charnwood Campus. \n2.50 – 3.00 – Professor Don Jones. Session close and collaborative opportunities. \n3.00 – 3.30 Networking and speaker slots. \n  \n Speaker Profiles\n \nProfessor Chris Brightling \nProfessor Chris Brightling’s research focusses on improving the clinical management and understanding the mechanisms of airway diseases such as asthma\, chronic coughs and COPD. He has published over 450 peer reviewed articles. Prof Brightling is a Fellow of the Academy of Medical Sciences\, National Institute for Health Research Senior Investigator\, Respiratory Theme Lead for Leicester NIHR Biomedical Research Centre\, Director Institute for Lung Health\, and Honorary Consultant Respiratory Physician. He is Coordinator of the MRC Molecular Pathology Node EMBER and Respiratory lead for the IMI 3TR and was founding Director of the European Respiratory Society Clinical Research Collaborations. \nProf Brightling is the national lead for the post-COVID consortium PHOSP-COVID and local research lead for the COVID-19 pandemic. His main research focus is on improving the clinical management and understanding the immunopathogenesis of the airway diseases asthma\, chronic cough and COPD.  He is a member of the American College of Chest Physicians’ Cough Guidelines\, the British Thoracic Society\, American Thoracic Society/European Respiratory Society Severe Asthma guidelines and is on the scientific committee for the Global INitiative for Asthma – GINA. Prof Brightling draws on his experience in research excellence and leadership to coordinate the research teams at the University of Leicester and three Leicestershire Partnership NHS Trust sites in their COVID-19 response. \n  \n \nProfessor Jacqui Shaw \nProfessor Shaw is Head of the Department of Genetics and Genome Biology\, Co-Director of the Institute for Precision Health and Professor of Translational Cancer Genetics at the University of Leicester. Her extensive expertise in innovative blood-based tests for monitoring breast and lung cancers\, known as liquid biopsies\, is highly sought after through national and international collaborations in clinical studies and trials. Professor Shaw’s research has found that breast cancer recurrence can be detected by a blood test up to two years ahead of when traditional screening techniques would be able to detect it. This highly impactful work enabled US-based genetic testing company Natera achieve the prestigious ‘Breakthrough Device’ designation from the U.S. Food and Drug Administration (FDA) in 2019 for their Signatera™ test\, which offers patients personalised cancer testing. \nProfessor Shaw’s research group’s expertise is in molecular diagnostics. This expertise was deployed during the coronavirus pandemic to establish and lead on asymptomatic screening for COVID-19 at the University of Leicester\, using a quick antigen test known as LAMP – Loop-mediated isothermal amplification. This screening programme has supported the University in the early detection of COVID-19 outbreaks on campus by detecting staff and students with asymptomatic cases who may have unknowingly spread the virus. \n  \n \nProfessor Pratik Choudhary \nProfessor Choudhary is an honorary consultant in Diabetes with a special interest in type 1 diabetes and technology. He has active clinical and research programs around education psychology and technology in type 1 diabetes. In particular\, using neuroimaging to explore mechanisms of hypoglycaemia unawareness and use of different strategies such as technology and behavioural interventions to restore awareness. \nProfessor Choudhary is currently chair of the Diabetes Technology Network-UK working to improve access to technology for diabetes through training education and advocacy. He has experience in academic and industry-funded early-phase studies evaluating novel glucose sensors and closed loop- artificial pancreas systems to help progress technologies\, and multinational randomised clinical trials (RCTs) and Real-World Evidence studies to support implementation and policy decisions that have enabled equitable access to developed technologies across the NHS. \n  \n \nDr James Hodgkinson \nResearch within the Hodgkinson Group is focused on the synthesis of novel chemical probes and compound libraries designed to study biological processes otherwise challenging by genetic approaches. We are specifically interested in developing chemical probes for Class I Histone Deacetylase (HDAC) enzymes and other protein partners that exist in Class I HDAC multiprotein complexes. Class I HDACs and their associated complexes have been implicated in diseases such as cancer and neurodegenerative disorders. Applications include using our chemical probes to investigate novel ligand-protein interactions and protein-protein interactions within HDAC complexes\, and developing heterobifunctional molecules including proteolysis targeting chimeras (PROTACs) for the targeted degradation of Class I HDACs and their associated complex partners in cancer cells. Our overall goal and vision is that our validated chemical probes will have direct applications for use by the members of chemical biology and biology communities in revealing new biology\, studying disease and ultimately aiding the discovery of new therapeutics. \n  \n \nProfessor Andre Ng \nProfessor Ng is an expert in the management of cardiac arrhythmias especially in catheter ablation and the use of mapping systems in such procedures. He has played a key role in the establishment of an active ablation programme for Atrial Fibrillation since 2002 at Glenfield Hospital and has pioneered the use of a novel robotic system in AF ablation. He has provided proctorship for new ablation technologies at many centres worldwide. He also specialises in advance device implantation including pacemakers\, implantable cardioverter defibrillators and cardiac resynchronisation therapy (CRT) devices. \nHe has translated important preclinical findings into investigations in cardiac patients with the successful development of a novel technology for sudden death risk stratification\, LifeMap\, which won numerous prizes including Medical Futures Award 2011 – Best Innovation in Diagnostics and European Heart Rhythm Association Inventors Award 2016\, resulting in several internationally granted patents. \n  \n \nProfessor Don Jones \nProfessor Jones is co-director of the Leicester van Geest Multi-OMICs Facility\, which is a world-leading centre for biomarker research. Professor Jones’ research involves discovering and implementing novel biomarkers of disease using mass spectrometry techniques\, with particular interest in the discovery of biomarkers (proteins\, metabolites and lipids) using state-of-the-art analytical techniques in combination with novel data interrogation techniques. From these projects the group are establishing targeted assays for biomarkers and working with pathology colleagues to validate and achieve clinical accreditation for assays. \nAs Co-director of Institute for Precision Health which helps coalesce precision medicine activity across the University and NHS. All this work helps to underpin the implementation of precision medicine by finding novel tools to personalise diagnosis and treatment in modern medicine. \nProfessor Jones plays an active role in the NIHR Biomedical Research Centre which allows this research to be translated into clinical use. \n  \n \nDr Lucy Alexander \nHead of Business Development and Senior Business Development Manager of Innovation Centre\, Charnwood at Charnwood Campus. I am passionate about research translation to real world product and have been delivering research commercialisation for over 25 years. Before joining the Campus\, I led the Leicester Life Sciences Accelerator\, focused on developing commercialisation of novel medicines and technologies with start-ups and SMEs. URL:https://www.medilinkmidlands.com/event/driving-innovation-in-midlands-healthcare/ LOCATION:Charnwood Campus Loughborough\, LE11 5RB\, Charnwood Campus Loughborough\, Loughborough\, LE11 5RB\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230425T090000 DTEND;TZID=Europe/London:20230426T160000 DTSTAMP:20260403T215945 CREATED:20230117T133413Z LAST-MODIFIED:20230124T100609Z UID:18801-1682413200-1682524800@www.medilinkmidlands.com SUMMARY:Making Pharmaceuticals 2023 DESCRIPTION:The leading UK Pharmaceutical Exhibition and Conference will take place in person on 25 and 26 April at the Coventry Building Society Area.  Attend to see 200+ companies exhibiting their latest products and services. network with pharmaceutical professionals and be part of the No.1 event in the UK for Pharmaceutical professional from research to finished product. \nThere will be 6 Industry Zones:\n– Cleanroom & Hygiene\n– Laboratory\n– Processing and Machinery\n– Ingredients & Raw Materials\n– Pharmaceutical Building Facilities\n– Pharmaceutical Manufacturing and Packing Zone \nFor more information or to book your stand visit www.makingpharma.com URL:https://www.medilinkmidlands.com/event/making-pharmaceuticals-2023/ LOCATION:Coventry Building Society Arena\, Judds Lane\, Coventry\, CV6 6GE\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230426T100000 DTEND;TZID=Europe/London:20230426T110000 DTSTAMP:20260403T215945 CREATED:20230323T133712Z LAST-MODIFIED:20230323T134434Z UID:22817-1682503200-1682506800@www.medilinkmidlands.com SUMMARY:WEBINAR: SEHTA & IVDeology Taster: The UKCA Mark: Are you ready? DESCRIPTION:SEHTA and IVDeology\, a leading regulatory company specifically within the in vitro diagnostic medical device industry\, are delighted to offer this webinar to start-up companies who are looking to place devices on the UK market. \nThe session will be delivered by Nancy Consterdine\, Director of Training and Compliance Services at IVDeology and will cover the following: \n Programme \n10:00 – 10:05 – Welcome & Introduction \n10:05 – 10:50 – Main presentation \n\nThe current requirements for placing devices on GB and NI markets – the clock is ticking\nThe role of the UK Representative and what to look for when appointing one\nThe best estimate of future requirements as directed by the consultation outcomes and recent MHRA communications including the role of the Qualified Person and transition timelines\n\n10:50 – 11:00 – Q&A \n11:00 – Close \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY URL:https://www.medilinkmidlands.com/event/webinar-sehta-ivdeology-taster-the-ukca-mark-are-you-ready/ LOCATION:Online CATEGORIES:Medilink Partner Event ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230426T123000 DTEND;TZID=Europe/London:20230426T130000 DTSTAMP:20260403T215945 CREATED:20230413T091650Z LAST-MODIFIED:20230413T092044Z UID:23102-1682512200-1682514000@www.medilinkmidlands.com SUMMARY:ONLINE SESSION: How to Create a Medical Device: Turning a Digital Health App into a Software-Based Medical Device DESCRIPTION:How do you turn a digital health app into a medical device? \nJoin this online session to gain insights from Tim Bubb\, Technical Director of IMed Consultancy. \nThis informal\, 25-minute session offers a beginner’s guide for companies and entrepreneurs who have an existing digital health app or product (or are looking to create one)\, and are interested in making it a software-based medical device in the UK. \nTopics to cover:\n·      When does a digital health product become a medical device?\n·      At what point to start thinking about medical device implications\n·      The steps people face on their way to medical device status\n·      The benefits / opportunities of qualifying your product as SaMD \nFor more details and to book your free place\, click here. URL:https://www.medilinkmidlands.com/event/nuom-how-to-create-a-medical-device/ LOCATION:Online CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230427T100000 DTEND;TZID=Europe/London:20230427T110000 DTSTAMP:20260403T215945 CREATED:20230330T184928Z LAST-MODIFIED:20230330T184928Z UID:22984-1682589600-1682593200@www.medilinkmidlands.com SUMMARY:EMAHSN Innovation Academy - Live Q&A - Module B: Pricing Mechanisms: An Introduction to the National Tariff Payment System DESCRIPTION:The East Midlands Academic Health Science Network Innovation Academy is open to anyone to register. Once registered\, participants will have access to a range of modules\, each including a webinar\, live Q&A session with the experts and online resources. The webinars are on demand\, so can be accessed at any time\, with the live Q&A session for each module being scheduled throughout 2023. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to Sign up for the Academy and to register for this module.\nThis module explores how the payment scheme in the NHS works. Chris delves deeper throughout his presentation on this and explains how money is allocated to NHS England. All of this occurs whilst Chris scopes out the structure of the national tariff in a user-friendly way. Patients are also coded within the NHS and this is broken down and explained in detail\, so one can come away from the presentation fully competent with this process. Finally\, the module highlights the way that money flows between providers and commissioners. \nPresenter / expert details\n\n\n Chris Skilbeck – Head of Engagement and Operations\, NHS England and Improvement URL:https://www.medilinkmidlands.com/event/emahsn-innovation-academy-live-qa-module-b-pricing-mechanisms-an-introduction-to-the-national-tariff-payment-system/ LOCATION:Online – GoToMeeting CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230427T130000 DTEND;TZID=Europe/London:20230427T160000 DTSTAMP:20260403T215945 CREATED:20230406T094026Z LAST-MODIFIED:20230406T094026Z UID:23020-1682600400-1682611200@www.medilinkmidlands.com SUMMARY:TBAT Innovation Challenge 2023 - Workshop 2 - People & Recruitment DESCRIPTION:This free-to-attend online workshop is designed to delve into the people and recruitment solutions you need to know in order to support your business growth. We will discuss problems\, challenges and highlight opportunities to reduce the effects of barriers within people and recruitment – supporting you on your journey to commercialisation and being a disrupter in the marketplace. \nIn this webinar\, we will cover: \n\nTalent and Recruitment\nThe role of a non-executive director\nEngaging and retaining your workforce\nInvestment and share incentives\nRecruiting the best people you can\n\nSpeakers include: \n\nSam Stephens – TBAT Innovation\nShakespeare Martineau – Roger Harcourt & Rhys Wyborn\nChris Hill – Vestd\nRachael Bull – Engage and Grow Central Midlands\nSimon Bucknell – EMBS\n\nThis event forms part of the wider TBAT Innovation Challenge 2023. \nCLICK HERE FOR MORE INFORMATION AND TO BOOK YOUR PLACE\nThe Innovation Challenge is brought to you by TBAT Innovation with headline sponsor Shakespeare Martineau and has been designed by our expert team to stimulate and support innovation in SMEs. It leverages the expertise of our unique partner network while seeing our partners come together to deliver four free to attend\, vibrant and informative workshops. \nOnce our final workshop has concluded in June\, the final stage of The Innovation Challenge will open. We will invite applications for businesses to submit a full business plan to be considered for our exciting prize package. \nThe winner will receive a £5\,000 cash prize and support packages from partners involved in The Innovation Challenge\, tailored to their needs. Furthermore\, two runners up will receive a free support package from partners involved in The Innovation Challenge. \nWe will be hosting a final showcase event in October 2023 to announce the winner from 10 finalists who will be invited to pitch their business plan in 3 minute presentation in front of key investors. URL:https://www.medilinkmidlands.com/event/tbat-innovation-challenge-2023-workshop-2-people-recruitment/ LOCATION:Online CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230427T183000 DTEND;TZID=Europe/London:20230427T213000 DTSTAMP:20260403T215945 CREATED:20230418T151315Z LAST-MODIFIED:20230426T143618Z UID:23116-1682620200-1682631000@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: Blüm Connect Launch DESCRIPTION:Dear friends and colleagues\, \nWe are excited to invite you to join us at the launch of Blüm Connect™\, our industry-disrupting solution that’s set to revolutionise the healthcare sector. For a long time at Blüm HQ\, we have recognised the pressing need for high-quality yet efficient digital health innovation\, and Blüm Connect is our response to this challenge. \nJoin us for an evening of networking\, refreshments and some amazing guest speakers including Rachel Murphy and David Plumb who will share their experiences of the digital health ecosystem. We will also hear from the Blüm Team about Blüm Connect – our solution that is providing NHS Trusts\, Universities\, and allied sectors with pre-built software features\, regulatory-compliant APIs\, and full code integrations. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nOur event is being hosted by Tech Canal\, an organisation that supports NHS adoption and sales capabilities by creating mutually beneficial partnerships to provide better outcomes\, and transform the delivery of health and care. Tech Canal plays a crucial role in closing the loop on our rapid innovation model\, making it easier for healthcare providers to adopt our solution. \nWe highly recommend registering early as space is limited. Please reserve your place here\, and join us as we collaboratively discover the future of healthcare innovation. We welcome you to also invite a technical lead / CTO colleague of your choice. \nOn behalf of the Blüm and Tech Canal Team. URL:https://www.medilinkmidlands.com/event/blum-connect-launch/ LOCATION:St Ethelburga’s Centre for Reconciliation and Peace Venue\, St Ethelburga's Centre for Reconciliation and Peace Venue 78 Bishopsgate London EC2N 4AG\, London\, EC2N 4AG\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230503T093000 DTEND;TZID=Europe/London:20230503T133000 DTSTAMP:20260403T215945 CREATED:20230330T115004Z LAST-MODIFIED:20230428T184725Z UID:22974-1683106200-1683120600@www.medilinkmidlands.com SUMMARY:Insights for Industry: Routes to Market and NHS Adoption DESCRIPTION:      \nThe aim of this industry-focused event\, hosted by Medilink Midlands and Nottingham Trent University (NTU)\, is to offer information and insights into routes to market and NHS adoption for new innovations. NHS Supply Chain work with partners such as NHS England\, NHS Improvement\, the National Institute for Health\, Care Excellence (NICE)\, and The AHSN Network to support the introduction of new technology and innovation into the NHS that provides demonstrable benefits for patients and users. \nThe event will be led by Marc Naughton and Fay Allen from the NHS Supply Chain team\, giving an overview of how procurement works in the NHS; the structure of hospital procurement and how it works in practice; key processes / stages / supports within the NHS Supply Chain\, as well as information on drivers for change and routes to market for novel innovation development. \nThe event is open to industry partners from across the region and will include tours of the facilities at NTU’s Clifton Campus including the Medical Technology Innovation Facility and the Institute for Heath and Allied Professions. \nCLICK HERE TO BOOK YOUR PLACE TODAY\nProgramme \n\n09:30 – Delegate registration and welcome refreshments\n10:00 – Welcome and Introductions\n10:05 – Marc Naughton\n10:25 – Fay Allen and Michaela Russell\n10:45 – Discussion & Q&A\n11:00 – BREAK – Networking and refreshments\n11:30 – Sachin Gohil\n11:50 – Q&A and Panel discussion\n12:00 – Lunch & Networking\n13:00-14:00 – Optional tour of MTIF/IHAP (approx. 1 hours and ends at Visitor Car Park)\n\nSpeaker Profiles \n \nMarc Naughton\, Clinical Engagement and Implementation Manager & Senior Pandemic\, NHS Supply Chain \nMarc has 23 years’ experience working for the NHS\, initially at the North West Ambulance Service as a Senior Paramedic and Manager. In 2015 he joined the Department of Health with the Clinical Evaluation Team to prove the concept that involving clinicians nationally within procurement could improve the quality\, safety and value of products used in the NHS. The success and alignment to Lord Carter Report into “unwarranted variation” helped to establish clinicians at the centre of NHS Supply Chain. After working to establish the Clinical and Product Assurance Team he joined Collaborative Procurement Partnership CPP in 2018 to help embed the clinical voice into procurement activity. Marc is currently focused on the following product areas. Orthoses and Podiatry\, Physiotherapy and Occupational Therapy\, Immobilisation and Prosthetics. \n \nFay Allen\, Innovation Specialist\, NHS Supply Chain \nFay has been a registered nurse for 24 years\, and has worked across the United Kingdom and Ireland\, in a variety of Roles and clinical specialties.  Fay Moved to NHS Supply chain 4 years ago as part of the Clinical and Product Assurance Directorate\, as a Product Assurance specialist\, her work in this area focused on Novel and new innovation products\,  co – developing the Innovation pathway with in NHS supply chain Focusing on eth Clinical need and the value for patients and Clinicians and her current position as Innovation Specialist. \nMichaela Russell\, Innovation Specialist\, NHS Supply Chain \nMichaela has worked in Procurement for 17 years\, across national and regional projects from Pharmaceuticals\, clinical and non-clinical procurement.  Areas of employment \, Resource procurement hub\, East Midlands pharmacy collaborative\, within local trust Nottingham University Hospitals before moving to NHS Supply chain 5 years ago as a category Tower Manager\, during this time she worked closely with NHSE on the Med Tech Funding Mandate policy and implemented this within NHS Supply chain\, this lead on to her co developing  the Innovation pathway  focusing on legal compliant routes for Innovations and her current position as Innovation Specialist. \n \nSachin Gohil\, Chief Commercial Officer\, Apos Health \nSachin is responsible for market adoption of Apos across the NHS. He has over 20 years of experience in healthcare\, having held clinical specialist and senior leadership roles at one of the largest acute Trusts in the UK. Previously\, Sachin was the Principal Pharmacist leading medicine optimisation programs at Optum UK. He is a passionate advocate for change and has led complex change processes within multi-provider organisations and systems\, acquiring a deep understanding of patient needs\, staff well-being\, and community development. URL:https://www.medilinkmidlands.com/event/ntu-nhs-supplychain/ LOCATION:Medical Technologies Innovation Facility (MTIF)\, Clifton Campus\, NTU\, Clifton Lane\, Nottingham\, Nottinghamshire\, NG11 8NS CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230503T093000 DTEND;TZID=Europe/London:20230503T133000 DTSTAMP:20260403T215945 CREATED:20230406T095525Z LAST-MODIFIED:20230406T095916Z UID:23022-1683106200-1683120600@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: Invitation to “Nurturing a Diverse and Sustainable Future in Life Sciences: A Comprehensive Approach to Equity and Inclusion” Workshop DESCRIPTION:  \nWe are excited to invite you to the upcoming workshop\, “Nurturing a Diverse and Sustainable Future in Life Sciences: A Comprehensive Approach to Equity and Inclusion.” delivered by Leicester Life Sciences Accelerator (LLSA). \nThe Leicester Life Sciences Accelerator (LLSA) delivers free innovation support to Leicestershire life sciences SMEs to increase knowledge exchange between clinicians\, academics\, and local companies to accelerate product development in partnership with the Midlands Engine. \nThis FREE workshop will equip you with the skills and knowledge needed to create a more diverse\, inclusive\, and sustainable culture in your organization. \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY\nThe workshop will be held at Charnwood Campus\, Loughborough\, and is part-funded by the European Regional Development Fund (ERDF). \nThe workshop will be delivered in two sessions: \n\nFirst session: “Internal Focus – Nurturing an equitable workforce and sustainable company”\nSecond session: “External Focus – Cultivating inclusive thinking and positive impact in product development”\n\nIf you have further questions\, please contact jacque.landry@leicester.ac.uk. URL:https://www.medilinkmidlands.com/event/in-person-event-invitation-to-nurturing-a-diverse-and-sustainable-future-in-life-sciences-a-comprehensive-approach-to-equity-and-inclusion-workshop/ LOCATION:Charnwood Campus Loughborough\, LE11 5RB\, Charnwood Campus Loughborough\, Loughborough\, LE11 5RB\, United Kingdom CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230509T130000 DTEND;TZID=Europe/London:20230509T140000 DTSTAMP:20260403T215945 CREATED:20230329T130944Z LAST-MODIFIED:20230505T091210Z UID:22889-1683637200-1683640800@www.medilinkmidlands.com SUMMARY:EMAHSN Innovation Academy – Live Q&A – Module C: Attracting Private Investment DESCRIPTION:The East Midlands Academic Health Science Network Innovation Academy is open to all. Once registered\, participants will have access to a series of 10 modules\, each including an on-demand webinar\, accompanying scheduled live Q&A session\, as well as a range of online resources. \nFor further details/to watch the ON-DEMAND webinar or join the live Q&A session please CLICK HERE to sign up for the Academy and to register for this module.\nLed by Gemma Sturt\, Investment Manager at Pioneer group\, this module supports innovators looking for private investment. Gemma provides an overview of the different types of investments and investors\, alongside timelines and mechanisms for obtaining funding. \nGemma discusses various routes including non-dilutive grants and awards\, emphasising the different types of funding that are potentially available. The session also covers venture capital\, outlining both the venture capital and associated due diligence process. \nIn this module\, you’ll learn how to approach investors strategically\, to give you the optimal chance of success. Finally\, the module highlights why research is so important when seeking to secure investment and advises on how to keep a targeted approach to attracting investment throughout your innovation journey. \nPresenter \n\n  \n  \n  \n  \nGemma Sturt\, Investment Manager\, Pioneer Group URL:https://www.medilinkmidlands.com/event/emahsn-innovation-academy-live-qa-module-c-attracting-private-investment/ CATEGORIES:Medilink Midlands Event END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20230510 DTEND;VALUE=DATE:20230511 DTSTAMP:20260403T215945 CREATED:20230222T160542Z LAST-MODIFIED:20230301T161247Z UID:22410-1683676800-1683763199@www.medilinkmidlands.com SUMMARY:Growth Through People 2023 DESCRIPTION:Growth Through People will be kicking off with our first event of the year on the 1st March 2023 with four weeks full of free\, expert-led event and webinars\, accompanied by digital content including blogs and podcasts. The series will culminate with the Growth Through People Conference\, to be held on the 10th May. \nUpcoming events: \n\nLeading and Managing Change in the Transition to Net Zero – Book Here\nIs a Four-Day Week the Future of Work? – Book Here\nEnsuring LGBTQ+ inclusivity in Your Workplace – Book Here\nHarnessing personal resilience in challenging times – Book Here\n\nGrowth Through People Conference \nJoin our conference this May to explore exceptional perspectives on themes including responsible leadership\, accessing and engaging talent\, unlocking potential and harnessing resilience. Take away new ideas to drive and inspire positive change within your business. \nThrough the 2023 Growth Through People conference\, we want to help local businesses learn the latest techniques\, advice\, guidance and view points on how to get the best out of their workforce during these challenging times. \nKeep an eye out for more details on our conference. \nFor full programme details\, please click here. URL:https://www.medilinkmidlands.com/event/growth-through-people-2023/ CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230510T093000 DTEND;TZID=Europe/London:20230510T133000 DTSTAMP:20260403T215945 CREATED:20230209T135310Z LAST-MODIFIED:20230502T134952Z UID:22185-1683711000-1683725400@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: The Fight Against Antibiotic Resistance: From Bench to Bedside DESCRIPTION:The first Infectious Diseases Special Interest Group of 2023 brings together academic\, clinician and industry experts to explore the latest developments in the field of antibiotic resistance. We’re pleased to be able to hold this event in person at MeetPoint Midlands\, allowing ample opportunity for networking and discussion beyond our exciting panel of formal presentations. \nOur Chair\, Professor Katie Laird\, Professor of Microbiology at De Montfort University (DMU)\, will be joined on the day by: \n\nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU\nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design\nStephanie Lesage\, Co-Founder and CEO\, Oxford Silk Phage Technologies Ltd\n\nMoreover\, delegates are invited to deliver a 5-minute pitch relating to the broader SIG area. Use this time as you wish – to invite knowledge exchange on a particular area of the subject\, showcase a new development that you’re currently working on\, and to highlight collaborative opportunities to other innovators and facilitators in attendance. \nInterested in delivering a 5-minute pitch? Please email info@medilinkmidlands.com with your name\, company\, and an overview of what you wish to share within your timeslot. \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all. \nCLICK HERE TO BOOK YOUR PLACE\nSpeaker Profiles \n \nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU \nPresentation topic: Designing a Biological Platform for High-Throughput Screening of Novel Antibacterial Compounds \nRahmi’s journey as a microbiologist began in her home country\, Indonesia\, after completing a Bachelor in Microbiology in 2008\, specialising in Industrial Microbiology. Following a number of short industry internships back home\, she enrolled in a graduate programme in Biomedical Engineering at Hochschule Furtwangen University\, Germany\, which she completed in 2012. Supported by a full government scholarship\, Rahmi then completed her doctoral studies at the University of Portsmouth in 2019\, researching the fundamental study of bacterial two-component systems and harnessing their potential as synthetic biosensors. Rahmi carried on this research for a further 2.5 years as a Senior Research Associate\, before joining the School of Pharmacy at DMU as Lecturer in Pharmaceutical Microbiology. \n \nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design \nPresentation title: Targeting Antibiotic Resistance through a Novel Class of Gram-Negative Antibacterial Agents \nDr Grace Edmund is a Senior Computational Chemist at Oxford Drug Design where she leads the computational chemistry effort for their tRNA synthetase antibacterial drug discovery project. Prior to joining Oxford Drug Design in 2015\, she completed post-doctoral research at the University of Surrey in collaboration with DSTL. She received her MChem in Chemistry from Durham University and PhD in Computational Chemistry from the University of Surrey. \n \nDr Stephanie Lesage\, Co-Founder & CEO\, Oxford Silk Phage Technologies Ltd \nPresentation title: Deploying Bacteriophages to Preserve Antibiotics \nStephanie Lesage has a multidisciplinary background in biological sciences (BSc)\, technical textile engineering (MEng) and medical devices (MSc)\, with 19 years of start-up leadership experience. She is CEO of Oxford Silk Phage Technologies Ltd\, a company she co-founded in 2020\, developing a novel antibacterial material integrating bacteriophages to produce medical implants which will reduce surgical site infections and antibiotic use. Stephanie is also a founding member of Phage-UK (2021)\, aiming to make phage therapy more widely available to UK patients and she was recently invited to the House of Commons to provide oral evidence on the potential for bacteriophage therapy in the UK. URL:https://www.medilinkmidlands.com/event/antibiotic-resistance/ LOCATION:MeetPoint Midlands\, Conference Centre\, 28 High Street\, Kegworth\, Derbyshire\, DE74 2DA CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230516T140000 DTEND;TZID=Europe/London:20230516T153000 DTSTAMP:20260403T215945 CREATED:20230420T093239Z LAST-MODIFIED:20230420T093239Z UID:23165-1684245600-1684251000@www.medilinkmidlands.com SUMMARY:WEBINAR: Investment\, Employee Incentivisation and R&D DESCRIPTION:SEHTA are pleased to bring you this webinar session with Accountancy firm Finerva – specialist advisers in finance\, accounting\, tax and beyond. \nThis session is ideal for you if you are an investor backed or may be seeking investor funding; wants to achieve a potential exit; has employees it wants to incentivise through shares in the company; or carrying out Research and Development. \nCLICK HERE TO BOOK YOUR PLACE TODAY \nDate:  Tuesday 16th May 2023 \nTime:  14:00 – 15:30 (BST) \nCost:    FREE for SEHTA members (£75 + VAT for non-members) \nPlatform:  TEAMS URL:https://www.medilinkmidlands.com/event/webinar-investment-employee-incentivisation-and-rd/ CATEGORIES:Other Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230517T093000 DTEND;TZID=Europe/London:20230517T133000 DTSTAMP:20260403T215945 CREATED:20230309T135351Z LAST-MODIFIED:20230630T075331Z UID:22595-1684315800-1684330200@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: NBIC Showcase: Supporting Collaboration for Impact in Biofilm Research DESCRIPTION:  \n  \nDelegates at this event will hear about the extensive opportunities offered by the National Biofilm Innovation Centre (NBIC) and Medilink Midlands to support collaboration between academia and industry in the area of biofilm research and innovation. Presentations and tours will provide an opportunity to see the state-of-the-art facilities available to characterize biofilms at the University of Nottingham or through NBIC partners. \nA selection of projects that exemplify successful collaborations between academia and industry will be presented by experts in the field\, and there will be the opportunity for delegates to pitch ideas for new collaborations. Networking will be facilitated over coffee and lunch breaks\, during the tours and by interacting with allied support organisations who will be present. \nInnovation vouchers are available\, please click here to access the guidance: Innovation voucher guidance\nAgenda\n09.30 Arrival/registration/coffee \n10.00 Welcome and introductions: Kim Hardie (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC) and Caroline Sykes (Medilink Midlands) \n10.05 Miguel Cámara (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC): ‘Introduction to NBIC: Nottingham research and infrastructure‘ \n10.25 Platform facilities at the University of Nottingham \n\nTim Self/Robert Markus: ‘School of Life Sciences Imaging (SLIM): a world class facility’\nDr Matthew Piggott: ‘Nanoscale & Microscale Research Centre (nmRC): Correlative Imaging and Compositional Analysis’\n\n10.40 Pitch 1: Paul S Browning\, Freedom Hygiene Ltd \n10.45 Pitch 2: Jinju Chen (Vicky)\, Newcastle University \n10.50 Paul Williams (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham): ‘Anti biofilm coatings on catheters’ TBC \n11.10 Coffee Break \n11.40 Alvaro Mata (School of Engineering\, University of Nottingham): ‘Biocooperative approaches to engineer biofilm models’ \n12.00 Sarah Kuehne (School of Dentistry\, University of Birmingham): ‘Oral biofilm models’ TBC \n12.20 Pitch 3: Jeni Luckett\, University of Nottingham \n12.25 Pitch 4: TBC \n12.30 Caroline Sykes (Medilink Midlands): ‘Nottingham City Shared Prosperity Fund opportunities.’ \n12.45 Summary and presentations conclude: Kim Hardie and Miguel Cámara \n13.00 Networking lunch \n13.30 Tours: \n\nBDI pathogen imaging/robots/compound library (Robert Markus)\nnmRC (Matt Piggott)\n\n15.30 Depart \nIn addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nDirections and Arrival Information: For directions to the University Park campus as well as a detailed campus map\, please click here. The event is taking place in at the Boots Science Building\, which is building number 44 on the campus map. \nOn arrival to the Boots Science Building\, you will find the Medilink Midlands registration desk in the main foyer\, where you will need to sign and collect your name badge. \nArriving by Car: We have a limited number of event parking spaces available to our attendees (not applicable to University of Nottingham attendees). If you require a car parking space\, please let me know as soon as possible as these will be offered on a first-come\, first-served basis\, for which you will require a parking voucher. Alternatively\, delegates can park in the main Visitors Car Park which is located at the bottom of E2 on the campus map. Please note that there is a short walk from the main car park to the venue and that parking is pay and display. The parking fee can be paid either at the machine or via the RingGo app at a cost of £7 for 4 hours or £10 for the full day. \nArrival by Tram: We recommend the tram as a convenient mode of transport for this event. The University of Nottingham stop on the Toton Lane line arrives directly opposite the Boots Science Building (you just need to exit the bridge via the stairs). Further information is available via the NetGo app\, where you can also buy e-tickets for your journey. \nTour of the NBIC facilities:In addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2/NG area and is open to all. URL:https://www.medilinkmidlands.com/event/nbic-showcase/ LOCATION:University of Nottingham School of Pharmacy CATEGORIES:Medilink Midlands Event END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230517T093000 DTEND;TZID=Europe/London:20230517T133000 DTSTAMP:20260403T215945 CREATED:20230330T121650Z LAST-MODIFIED:20230515T142141Z UID:22979-1684315800-1684330200@www.medilinkmidlands.com SUMMARY:IN-PERSON EVENT: 3D Technologies and Augmented Reality: Improving Surgical Planning and Intervention DESCRIPTION:The next MedTech & Systems Special Interest Group event will be held in person\, with a focus on the latest developments in 3D technologies and augmented reality. The presentations will consider how these fields are creating significant improvements in surgical planning and intervention. \nToday\, the use of Augmented Reality (AR) and Virtual Reality (VR) in healthcare is expanding. Augmented Reality\, Virtual Reality and Extended Reality (XR) are now much more common terms linked to the delivery of realistic interactive experiences through real-life simulation and user immersion. Technologies including the Microsoft HoloLens and the Vuzix AR platforms have provided additional and exciting possibilities linked to healthcare and surgery. Surgeons rely on information from CT scans\, MRI’s\, X-rays and other patient data sources to determine surgical requirements and to preoperatively plan prior to a surgical procedure. If using wearable technologies\, this data could be represented in a surgeon’s line of sight\, utilising AR tools to potentially provide significant surgical procedural advantages during an operation and ultimately improve patient outcomes. \nChaired by Professor Phil Breedon\, Professor of Smart Technologies at Nottingham Trent University\, this session brings together a panel of leading experts\, including: \n\nJason Watson\, Consultant Maxillofacial Prosthetist\, Nottingham University Hospital\nRory O’Connor\, Consultant in Oral and Maxillofacial Surgery and Major Trauma\, Nottingham University Hospital\nDr Arsham Khayatpoor\, Medical Account Manager\, Materialise UK\n\nThis in-person event will also allow ample time for Q&A and networking. \nCLICK HERE TO SECURE YOUR PLACE TODAY\nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2/NG area and is open to all. \nSpeaker Profiles \n \nJason Watson\, Consultant Clinical Scientist in Reconstructive Science\, Nottingham University Hospitals Trust \nJason completed his post graduate training at the Northern General Hospital\, Sheffield\, in the 1990s. Jason started his my own unit in Nottingham at the QMC in 2002\, where the laboratory has become one of the most innovative centres in the field of Maxillofacial Prosthetics and Reconstructive Science. \nJason has published over 30 papers and book chapters. He has also received national awards including the Chief Scientific Officers Award for Leadership and Innovation 2010 in recognition for establishing the first in-house 3D print service in the NHS. Jason has collaborated on numerous i4i and EPSRC grants (Loughborough University/Kings College & Leeds University) in the field of 3D acquisition\, printing and manufacture. \nJason co-wrote the Scientist Trailing Programme (STP) in Reconstructive Science (level 7) and was lead writer on the Higher Specialist Scientist (HSST) Consultant training (level 8) with the National School Healthcare Science and Royal College Surgeons (England). He established NUH as the field’s regional training centre in 2006 and has had the highest number of successful trainees through the national programme (STP) since its inception in 2013. Jason was invited by the British Association Oral Maxillofacial Surgeons (BAOMS) to deliver the Presidents Lecture in 2020\, becoming only the second scientist to do so in their history. Jason has been an active professional body council member throughout his career\, serving in numerous roles culminating in 3 years as the Chair of our association (IMPT) \nCurrently I enjoy exploring emerging technologies for clinical and technical use in real life situations\, sharing ideas and collaborating with new colleges\, cars\, motorbikes\, travel and food. \n \nRory O’Connor\, NHS Consultant in Oral and Maxillofacial Surgency and Major Trauma\, Queen’s Medical Centre\, Nottingham \nRory is an expert in facial trauma and post traumatic facial deformity with a particular focus on how technology can improve patient outcomes and make treatments more efficient. He has worked as a doctor all over the East Midlands\, in London\, Cambridge and Switzerland and is keen to collaborate with anyone who would like to improve how we look after the patients of the future. \n \nDr Arsham Khayatpoor\, Medical Account Manager\, Materialise URL:https://www.medilinkmidlands.com/event/in-person-event-3d-technologies-and-augmented-reality-improving-surgical-planning-and-intervention/ LOCATION:Dryden Enterprise Centre\, Nottingham CATEGORIES:Medilink Midlands Event ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com END:VEVENT BEGIN:VEVENT DTSTART;TZID=Europe/London:20230518T120000 DTEND;TZID=Europe/London:20230518T124000 DTSTAMP:20260403T215945 CREATED:20230427T105916Z LAST-MODIFIED:20230427T105916Z UID:23271-1684411200-1684413600@www.medilinkmidlands.com SUMMARY:WEBINAR: Taking Your Medical Device to the US - It's Not As Hard As You Think DESCRIPTION:  \nWith the regulatory environment remaining complex in the EU and UK\, we’re seeing an uptick in requests for support with entering the US market. \nCome and join Timothy Bubb\, Technical Director at IMed Consultancy and Kevin Malecek\, Director of Economic Development and International Trade for the City of Mentor\, Ohio\, as we debunk some myths and reveal how a different approach to regulation need not mean it’s more difficult to get products on the market! \nCLICK HERE TO BOOK YOUR FREE PLACE TODAY URL:https://www.medilinkmidlands.com/event/webinar-taking-your-medical-device-to-the-us-its-not-as-hard-as-you-think/ CATEGORIES:Medilink Midlands Event END:VEVENT END:VCALENDAR